Ernexa Therapeutics Inc. (ERNA) › Total AssetsErnexa Therapeutics Inc. (ERNA) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $13.12M2011: $11.65M2012: $12.66M2013: $15.46M2014: $22.27M2015: $16.41M2016: $16.70M2017: $16.57M2018: $14.86M2019: $14.12M2020: $12.91M2021: $31.52M2022: $22.28M2023: $49.13M2024: $5.27M2025: $5.83M$5.83M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$5.83M+10.7%2024$5.27M-89.3%2023$49.13M+120.5%2022$22.28M-29.3%2021$31.52M+144.3%2020$12.91M-8.6%2019$14.12M-5.0%2018$14.86M-10.3%2017$16.57M-0.7%2016$16.70M+1.7%2015$16.41M-26.3%2014$22.27M+44.1%2013$15.46M+22.1%2012$12.66M+8.7%2011$11.65M-11.3%2010$13.12M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share